Treatment of early Parkinson’s disease

John C. Morgan, Kapil D. Sethi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

From the time of the original description of Parkinson’s disease (PD)1 until the 1960s, the pharmacotherapy of PD was not too complex a matter: anticholinergics were the cornerstone of treatment. The introduction of levodopa in the 1960s and the proof of its effectiveness in the treatment of PD2 have resulted in vastly improved quality of life and reduction of disability in PD patients. Today, there are many choices in the initial pharmacological treatment of early PD,3-9 each having its own strengths and weaknesses. The goal of this chapter is to provide a sound rationale for initial pharmacotherapy in early PD, based upon current scientific evidence and personal experience.

Original languageEnglish (US)
Title of host publicationParkinson's Disease, Second Edition
PublisherCRC Press
Pages1029-1041
Number of pages13
ISBN (Electronic)9781439807156
ISBN (Print)9781439807149
DOIs
StatePublished - Jan 1 2012

    Fingerprint

ASJC Scopus subject areas

  • Neuroscience(all)
  • Medicine(all)

Cite this

Morgan, J. C., & Sethi, K. D. (2012). Treatment of early Parkinson’s disease. In Parkinson's Disease, Second Edition (pp. 1029-1041). CRC Press. https://doi.org/10.1201/b12948